| NDC Code |
42192-341-30 |
| Proprietary Name |
Prenaissance |
| Package Description |
30 CAPSULE, LIQUID FILLED in 1 CAPSULE (42192-341-30) |
| Product NDC |
42192-341 |
| Product Type Name |
HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name |
CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, DOCUSATE SODIUM and DOCONEXENT |
| Dosage Form Name |
CAPSULE, LIQUID FILLED |
| Route Name |
ORAL |
| Start Marketing Date |
20110519 |
| Marketing Category Name |
UNAPPROVED DRUG OTHER |
| Labeler Name |
Acella Pharmaceuticals, LLC |
| Substance Name |
.ALPHA.-TOCOPHEROL, D-; ASCORBIC ACID; CHOLECALCIFEROL; DOCONEXENT; DOCUSATE SODIUM; FERROUS FUMARATE; FOLIC ACID; PYRIDOXINE HYDROCHLORIDE; TRICALCIUM PHOSPHATE |
| Strength Number |
30; 28; 800; 325; 55; 29; 1.25; 25; 160 |
| Strength Unit |
[iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |
Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Vitamin D [Chemical/Ingredient],Vitamin D [EPC] |